Janux Therapeutics, Inc. · NASDAQ:JANX
Janus Henderson Group PLC reported a 0.30% stake in Janux Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 13, 2026
Janus Henderson Group PLC reported a 0.30% stake in Janux Therapeutics, Inc., 172,229 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G/A).
- Stake
- 0.30%
- Shares
- 172,229
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP Ltd. | 0.30% | 172,229 |
Source
Related
- Janux Therapeutics, Inc.
- Janus Henderson Group PLC
- Janux Therapeutics, Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Feb 17, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Nov 7, 2025
- Schedule 13G/A · Janus Henderson Group PLC · Aug 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · May 14, 2025
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Form 4 · Campbell David Alan · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Campbell David Alan · Jul 10, 2026
- Form 4 · RA Capital Nexus Fund II, L.P. · Jun 12, 2026